3-(2-Methoxy-5-nitrophenyl)pyrrolidine | 648901-40-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 3-(2-Methoxy-5-nitrophenyl)pyrrolidine
• CAS: 648901-40-0
• 化学式: C11H14N2O3
• 分子量: 222.24
• InChiKey: YVIRXUDINPAEQQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  67.1
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• 1,2-cyclohexylaminoaryl amides useful as analgesic agents
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP0380063A1

  公开（公告）日：1990-08-01

  Novel 1,2-cyclohexylaminoaryl amides of formula I are useful as analgesic agents having very high kappa-opioid affinity and selectivity and potency and are useful as analgesics, diuretics, antiinflammatory and psychotherapeutic agents. Methods for making the compounds and pharmaceutical compositions containing them are also disclosed.

  式 I 的新型 1,2-环己基氨基芳酰胺可用作镇痛剂，具有极高的卡巴阿片亲和力、选择性和药效。 可用作镇痛剂，具有极高的卡帕-阿片类亲和力、选择性和效力，可用作镇痛剂、利尿剂、消炎剂和精神治疗剂。 此外，还公开了制造这些化合物的方法以及含有这些化合物的药物组合物。
• US4906655A
  申请人：——

  公开号：US4906655A

  公开（公告）日：1990-03-06
• US5019588A
  申请人：——

  公开号：US5019588A

  公开（公告）日：1991-05-28
• [EN] SUBSTITUTED BENZANILIDES AS MODULATORS OF THE CCR5 RECEPTOR<br/>[FR] BENZANILIDES SUBSTITUES UTILISES COMME MODULATEURS DU RECEPTEUR CCR5
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2004010943A2

  公开（公告）日：2004-02-05

  This invention relates to substituted benzanilides which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to, asthma and atopic disorders (for example, atopic dermatitis and allergies), rheumatoid arthritis, sarcoidosis and other fibrotic diseases, atherosclerosis, psoriasis, autoimmune diseases such as multiple sclerosis, and inflammatory bowel disease, all in mammals, by the use of substituted benzanilides which are CCR5 receptor antagonists. Furthermore, since CD8+ T cells have been implicated in COPD, CCR5 may play a role in their recruitment and therefore antagonists to CCR5 could provide potential therapeutic in the treatment of COPD. Also, since CCR5 is a co-receptor for the entry of HIV into cells, selective receptor modulators may be useful in the treatment of HIV infection.